Background We investigated factors that influenced oral anticoagulant (OAC) initiation and
choice in Australian general practice patients newly diagnosed with AF. Methods Using an …

Aims Recent increases in the number of patients with atrial fibrillation (AF) prescribed oral
anticoagulants (OAC) are evident in Ireland and internationally, largely due to the availability …

Aims Persistence with direct oral anticoagulants (DOACs) has become a concern in non-
valvular atrial fibrillation (NVAF) patients, but whether this affects prognosis is rarely studied …

Anticoagulant therapy is an effective stroke prevention measurement for subjects with atrial
fibrillation (AF) who are at high risk of ischemic stroke. However, it is reported that oral …

Atrial fibrillation (AF) is a growing public health concern and remains an independent risk
factor for ischemic stroke. Warfarin, a commonly used oral anticoagulant, is associated with …

Importance Patients with atrial fibrillation (AF) are at a proportionally higher risk of stroke
based on accumulation of well-defined risk factors. Objective To examine the extent to which …

Background Underuse of oral anticoagulation (OAC) for stroke prevention in atrial fibrillation
(AF) results in thousands of preventable strokes in Germany each year. This study aimed to …

Introduction: Oral anticoagulation (OAC) is given for ischemic stroke prevention in patients
with nonvalvular atrial fibrillation. OAC's most serious complications are major bleeding and …

Background: Real-world evidence from published observational studies of adherence to
Novel Oral Anticoagulants (NOACs) medications and associated clinical outcome events in …

Purpose Poor adherence to non-vitamin K antagonist oral anticoagulants (NOACs) may
raise thromboembolic risks in patients with atrial fibrillation (AF). However, the minimal …